commented Carl Schmid.

Brown concluded.. AIDS Institute proposes raises for Helps level and medications financing for prevention ‘The Helps Institute thanks Chairman Tom Harkin for his leadership in maintaining the United States Senate’s solid commitment to domestic HIV programs by increasing funding for the AIDS Drug Assistance Program and maintaining funding for HIV prevention and other areas of the Ryan White colored HIV/AIDS Plan,’ commented Carl Schmid, Deputy Executive Director of The Helps Institute. ‘We are grateful that of these difficult fiscal times, Chairman Harkin and his colleagues recognize the need for the federal government’s part in preventing infectious illnesses, such as for example HIV, and the necessity to provide care and treatment to people living with HIV/AIDS to keep them healthy and reduce new infections,’ continued Schmid.‘FusionVax is certainly well-positioned to help expand develop ADXS-HPV clinically and to realize its commercial worth in Asia across multiple HPV-linked cancers,’ commented Daniel J. O'Connor, Senior Vice President, Chief Legal and Business Advancement Officer of Advaxis. ‘With five studies currently in the field in four indications, we continue steadily to broaden our data. This MoU may be the first milestone on Advaxis' way to future licensing possibilities,’ commented Thomas A.